Resources

Discover our Resources

Learn about the validated science behind DXcrete, explore our proprietary data insights, and meet our data collection partners
About our Resources
Sweat is a biofluid which is rich in biomarkers and can be noninvasively sampled and is therefore the ideal candidate for semicontinuous health monitoring.
Meet the team behind the science.

Publications

Scientific papers on hydration physiology, including insights from DXcrete
Wearable sweat sensing for prolonged, semicontinuous, and nonobtrusive health monitoring
October 15, 2020
Read Publication
Discretised microfluidics for noninvasive health monitoring using sweat sensing†
November 6, 2024
Read Publication

Measuring Sweat Without Sweating

Measuring Without Needles or Sweating
Read the article

Innovations in Sweat Sensing Devices

Stay updated on the latest innovations in sweat sensing technology.
Read the article

The Role of Sweat in Fitness

Explore how sweat plays a crucial role in fitness and performance.
Read the article

Biomarkers in Sweat: What They Reveal

Learn about the key biomarkers found in sweat and what they can tell us about our health.
Read the article

The Future of Wearable Health Tech

Discover how sweat sensing technology is shaping the future of wearable health devices.
Read the article

Understanding Sweat Sensing Technology

Explore the innovative world of sweat sensing technology and its applications in health monitoring.
Read the article
Built on research

Born at TU/e. Published, patented, funded.

1st
wearable with integrated electrowetting that collects and moves sweat on the body, published in 2024.
3
patents protecting the core technology.
€185k
NWO Faculty of Impact funding.
2026
first patient studies planned, on the way to CE marking.
"Strongest clinical recommendation: daily measurement in early phase."
Prof. Joris Rotmans
Head of nephrology, LUMC
DXcrete advisory board
"Limiting factor today: daily kidney measurement is not possible."
Prof. Pim Tonino
Interventional cardiologist
Catharina Hospital
"Greatest cardiorenal urgency — cardiologists too aggressive."
Dr. Peter Luik
Internist-nephrologist, Meander MC
Board NFN
the problem

A massive problem
still unsolved

Chronic kidney disease is healthcare's most expensive underdiagnosed condition. DXcrete enters a market primed for a monitoring paradigm shift.
1-in-7
people live with CKD worldwide
90%
are completely unaware they have it
850M
annual economic burden
300B
5th projected cause of death by 2040